Literature DB >> 33402079

An Update on the Recent Advances in Cubosome: A Novel Drug Delivery System.

Madhukar Garg1, Anju Goyal1, Sapna Kumari1.   

Abstract

Cubosomes are highly stable nanostructured liquid crystalline dosage delivery form, derived from amphiphilic lipids and polymer-based stabilizers converting it in a form of effective biocompatible carrier for the drug delivery. The delivery form comprised of bicontinuous lipid bilayers arranged in three-dimensional honeycombs like structure provided with two internal aqueous channels for the incorporation of many s biologically active ingredients. In contrast to liposomes, they provide a large surface area for the incorporation of different types of ingredients. Due to the distinct advantages of biocompatibility and thermodynamic stability, cubosomes have remained the first preference as a method of choice in the sustained release, controlled release, and targeted release dosage forms as new drug delivery system for the better release of the drugs. As a lot of advancement in the new form of dosage form brought the novel avenues in drug delivery mechanisms, so it was a matter of worth to compile the latest updates on the various aspects of the mentioned therapeutic delivery system including its structure, routes of applications along with the potential applications to encapsulate variety drugs to serve health-related benefits. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Cubosome; amphiphilic; bicontinuous; cubic phase; drug delivery.; nanoparticles

Mesh:

Substances:

Year:  2021        PMID: 33402079     DOI: 10.2174/1389200221666210105121532

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  1 in total

Review 1.  Bioactive Loaded Novel Nano-Formulations for Targeted Drug Delivery and Their Therapeutic Potential.

Authors:  Sapna Kumari; Anju Goyal; Eda Sönmez Gürer; Evren Algın Yapar; Madhukar Garg; Meenakshi Sood; Rakesh K Sindhu
Journal:  Pharmaceutics       Date:  2022-05-19       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.